Examkin

Question

Difficulty: HardGynecologic Oncology

Review the clinical scenarios detailing specific presentations and histopathologic findings of various gynecologic neoplasms. Match each patient vignette with the most appropriate primary serum tumor marker used for disease surveillance.

  • A 23-year-old woman undergoes unilateral salpingo-oophorectomy for an acute abdomen; surgical pathology reveals a malignant neoplasm characterized by Schiller-Duval bodies.Alpha-fetoprotein (AFP)
  • A 33-year-old woman presents with hemoptysis and irregular vaginal bleeding four months following a spontaneous abortion; chest imaging shows multiple pulmonary nodules.Quantitative β\beta-hCG
  • A 68-year-old woman presents with massive ascites and early satiety; ascitic fluid cytology reveals malignant epithelial cells with papillary architecture and psammoma bodies.Cancer antigen 125 (CA-125)
  • A 42-year-old woman is found to have a 20 cm20\text{ cm} multiloculated adnexal cyst with mucoid material in the abdomen, raising suspicion for pseudomyxoma peritonei.Carcinoembryonic antigen (CEA)
  • A 54-year-old postmenopausal woman with new-onset vaginal bleeding is found to have an adnexal mass; initial office endometrial biopsy reveals simple hyperplasia without atypia.Inhibin

Answer

The clinical and histologic findings match specific gynecologic malignancies and their corresponding serum tumor markers: Yolk sac tumor (AFP), Choriocarcinoma (quantitative β\beta-hCG), Serous epithelial carcinoma (CA-125), Mucinous carcinoma (CEA), and Granulosa cell tumor (Inhibin).
Each tumor marker acts as a crucial surveillance tool tailored to the tumor's cellular origin. Germ cell yolk sac tumors secrete AFP; gestational trophoblastic neoplasias like choriocarcinoma secrete β\beta-hCG; serous epithelial cancers express CA-125; mucinous tumors express CEA; and granulosa cell tumors secrete inhibin.

Step-by-Step Solution

1
Analyze the diagnostic clues in each patient vignette to determine the specific histologic subtype of the gynecologic neoplasm.
The vignettes describe a yolk sac tumor, a choriocarcinoma, a serous epithelial carcinoma, a mucinous carcinoma, and a granulosa cell tumor.
Accurate histologic diagnosis dictates which specific serum biomarker will be elevated and clinically useful for monitoring.
2
Correlate the identified germ cell and trophoblastic neoplasms with their classic secretory products.
The yolk sac tumor (Schiller-Duval bodies) pairs with AFP; the choriocarcinoma (post-pregnancy bleeding with lung metastases) pairs with quantitative β\beta-hCG.
Germ cell and trophoblastic tumors have highly specific embryonic markers that correlate directly with tumor burden.
3
Correlate the epithelial and sex cord-stromal neoplasms with their respective tracking markers.
Serous carcinoma pairs with CA-125; mucinous carcinoma pairs with CEA; the granulosa cell tumor (causing endometrial hyperplasia via excessive estrogen) pairs with Inhibin.
Differentiation between epithelial subtypes and sex cord-stromal tumors is strictly necessary to select the correct surveillance assay, as they arise from distinct cellular lineages.

Key Concept

Correlation of specific gynecologic neoplasms with their characteristic clinical presentations, histopathology, and primary serum tumor markers used for surveillance.
Rate this question

Topics

Gynecologic Oncology

More questions from this topic